Data for: Astemizole analogues with reduced hERG inhibition as potent antimalarial compounds
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Supplementary Information
应用场景：
创建时间：
2017-10-15
相关数据集
β‑Hydroxy- and β‑Aminophosphonate Acyclonucleosides as Potent Inhibitors of Plasmodium falciparum Growth
Malaria is an infectious disease caused by a parasite of the genus Plasmodium, and the emergence of parasites resistant to all current antimalarial drugs highlights the urgency of having new classes o
NIAID Data Ecosystem30
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy
The antiplasmodial activity, DMPK properties, and efficacy of a series of quinoline-4-carboxamides are described. This series was identified from a phenotypic screen against the blood stage of Plasmod
Figshare2016-09-01 更新20
Su, A. Synthesis of Antimalarial Compounds from the Triazolopyrazine Ether Series
Alexander Su, Open Souce Malaria paper 2015
Figshare2016-01-20 更新10
Proteomic Analysis of Artemisia annua
There is growing interest to apply proteomics to other organisms than just the biomedically relevant and important species such as human, mouse or rat. However, one of the main hurdles for successful
NIAID Data Ecosystem30
MS-CETSA Target Identification of MMV compounds: MMV007127, MMV665886
ITDR MS-CETSA was conducted on MMV compounds-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets. MMV compounds: MMV007127, MMV665886.
NIAID Data Ecosystem10
